THE TCF/LEF FAMILY OF TRANSCRIPTION FACTORS
The founding members of the TCF/LEF family of transcription factors, TCF-1 and LEF-1, were identified in screens for T cell-specific transcription factors. TCF-1 was identified by its ability to bind to the CD3 enhancer, whereas LEF-1 was found in a screen for proteins binding to the TCR␣ enhancer and a site in the HIV LTR van de Wetering et al., 1991; Travis et al., 1991; Waterman et al., 1991) . In more recent years, two additional family members were identified in mammals: TCF-3 and TCF-4 (Korinek et al., 1998a) . The Drosophila genome only contains one TCF gene, called dtcf or pangolin (Brunner et al., 1997; van de Wetering et al., 1997) . Similarly, a single gene resides in the genome of the nematode Caenorhabditis elegans, Pop-1 (Lin et al., 1995) .
Proteins of the TCF/LEF family contain an 80-amino-acid high mobility group (HMG) box. HMG boxes bind DNA as monomers and can do so Laudet et al., 1993) in a sequence-specific manner (Laudet et al., 1993) . The TCF consensus recognition sequence is remarkably conserved between the family members and comprises AGATCAAAGGG Giese et al., 1991; van Beest et al., 2000) . The HMG box not only mediates DNA sequence recognition, but coincidently induces a dramatic bend in the DNA (Giese et al., 1992; Dooijes et al., 1993) . By doing so, HMG boxes may coordinate the binding of other transcription factors Giese et al., 1995; Bianchi and Beltrame, 1998) . Because of this bending ability and the observation that TCF factors cannot directly activate transcription in reporter assays, it has been proposed that TCF/LEF family members primarily serve an architectural function. LEF-1 appears unique in that it contains a context-dependent activation domain (CAD) (Carlsson et al., 1993) , which can activate transcription in the presence of the coactivator ALY (Bruhn et al., 1997) . The other TCF family members do not appear to contain a CAD domain . TCF/Lef mRNAs undergo extensive alternative splicing. The best studied gene, TCF-1, also exhibits alternative promoter usage. Over 100 Tcf-1 isoforms may theoretically be produced. However, Western blotting has revealed the predominant expression of eight different TCF-1 protein isoforms . LEF-1 exhibits two splice variants (Waterman et al., 1991) and also possesses two promoters (Hovanes et al., 2001) . Several C-terminal splice variants exist of TCF-4 that exhibit strong sequence homology to similar TCF-1 mRNAs Duval et al., 2000) (Fig. 1) . While the functional relevance of the alternative splice products in TCF/Lef genes remains unclear at present, alternative promoter usage in the TCF-1 and LEF-1 gene generates protein isoforms that either carry or lack the N-terminal ␤-catenin interaction domain (see below).
TCF/LEF KNOCKOUT MICE
The molecular context in which the TCF family of transcription factors functions remained mysterious for years. Knockout mice have been generated for three murine Tcfs. In adult animals, Tcf-1 is expressed in T lymphocytes. Indeed, Tcf-1 Ϫ/Ϫ knockout mice are impaired in the generation of T lymphocytes (Verbeek et al., 1995) . Their thymuses are reduced in size and show a 10-to 100-fold reduction in T cell numbers compared with heterozygous littermates (Verbeek et al., 1995) . Nevertheless, the Tcf-1 Ϫ/Ϫ mice are fully immunocompetent, have functional peripheral T cells, have a normal lifespan, and are fertile (Schilham et al., 1998) . Closer examination of the thymocytes from 4-to 6-week-old animals revealed proliferative abnormalities at several precursor stages, which are normally characterized by extensive cell expansion (Schilham et al., 1998) . However, mature T cells as present in spleen and lymph nodes are fully competent upon encountering mitogens or antigens. Tcf-1 thus appears essential for the maintenance of early thymocyte progenitors.
More recently, it was found that Tcf-1 Ϫ/Ϫ mice develop adenomas in the gut and the mammary glands. This led to the hypothesis that Tcf-1 is a target gene of Tcf-4/␤-catenin signaling in the intestine (Roose et al., 1999) . The predominantly expressed isoform of Tcf-1 in the gut lacks the N-terminal ␤-catenin interaction domain and may function in a negative feedback loop.
Lef-1 Ϫ/Ϫ knockout mice have a more complex phenotype. During embryogenesis, Lef-1 is expressed at many different sites, including the tel-, di-, and mesencephalon, tooth germs, whisker follikels, mammary buds, thymus, limb buds, and tail vertebrae (Oosterwegel et al., 1993; Zhou et al., 1995; van Genderen et al., 1994) . Mice homozygous for a mutation in the Lef gene die shortly after birth and show deficiencies in some but not all organs normally expressing Lef-1 (van Genderen et al., 1994) . Most strikingly, these mice lack body hair and whiskers. Although follicle formation starts at the proper time point, only one-third of normal hair follicle numbers is found later in development. These hair follicles are short and rudimentary. These Lef-1 Ϫ/Ϫ mice also lack teeth. The tooth germs are indistinguishable from wild-type counterparts at the bud stage (E13). Yet, normal progression of the Lef-1 Ϫ/Ϫ buds to the late cap stage (E15) is halted (van Genderen et al., 1994) . Newborn Lef1 Ϫ/Ϫ females reveal a stunted development of mammary glands. The mutant mice also lack the trigeminal nucleus. Unexpectedly, the mice did not show any obvious defects in lymphoid cell populations at birth, despite the fact that Lef-1 is expressed in B-cells (van Genderen et al., 1994) . Nevertheless, it was shown in a recent study that Lef-1 mediates proliferation of early B lineage cells in vitro (Reya et al., 2000) .
Tcf-1/Lef-1 double knockout mice made with a hypomorphic Tcf-1 allele display a very severe defect in T cell differentiation, but no developmental defects. ␣/␤ T cell differentiation is completely blocked at the immature single positive (ISP) stage and clearly impaired at earlier stages (Okamura et al., 1998) . Crossing a null-allele of Tcf-1 into Lef-1 knockout mice yields an early embryonic phenotype that resembles that of Wnt-3A. Severe defects occur in the differentiation of the paraxial mesoderm, resulting in the formation of additional neural tubes. These embryos also show defects in placenta formation and in the formation of the apical ectodermal ridge of the limb buds. These data indicate extensive functional redundancy between Tcf-1 and Lef-1 in early T lymphocytes and during embryonic development (Galceran et al., 1999) .
Tcf-4 is expressed from E10.5 onward in the developing CNS, where it partially overlaps with Lef-1 expression. Tcf-4 expression is particularly striking in gut epithelium throughout life (Korinek et al., , 1998a . Tcf-4 Ϫ/Ϫ mice die shortly after birth and display a single phenotypic abnormality, the complete absence of the stem cell compartment in the crypts of the small intestine (Korinek et al., 1998b) . The organization of the pseudostratified epithelium in the small intestine of mutant embryos shows no aberrations at day 14.5 compared with control littermates. At day 16.5, however, a reduced number of cells populates the prospective crypt region and the number of villi is reduced (Korinek et al., 1998b) . Closer examination of the cells populating the prospective crypt regions reveals a lack of actively dividing crypt cells, implying that Tcf-4, like Tcf-1, functions to maintain early progenitor cells.
BINDING PARTNERS OF TCF
The identification of binding partners of TCF/LEF eventually revealed their molecular context. The first protein found to interact with TCF/LEF factors was the Wnt signaling effector ␤-catenin (Molenaar et al., 1996; Behrens et al., 1996) . Using multimerized TCF binding motifs upstream of a reporter gene, it became apparent that cotransfection of TCF with ␤-catenin strongly induced transcription (Molenaar et al., 1996) . All members of the TCF family can bind ␤-catenin through a conserved N-terminal stretch of 55 amino acids. ␤-Catenin thus functions as a classical coactivator of transcription. A potent transcriptional activation domain maps to its C terminus. Recent studies have indicated that this domain serves to modify local chromatin. The histone acetylase CBP was found to interact directly with the transactivation domain of ␤-catenin and synergizes with the latter protein to enhance transcription of a reporter gene in vivo (Takemaru and Moon, 2000) . Similarly, the C-terminal transactivation domain of ␤-catenin binds to Brg-1, a core component of the mammalian Swi/ Snf chromatin remodeling complex. Binding of Brg-1 to ␤-catenin enhances transcription of Tcf target genes (Barker et al., 2001) .
Another binding partner of TCF, Grg-5, is related to Drosophila Groucho, which in turn is the founding member of a family of broadly expressed transcriptional corepressors. Grg proteins interact with histone deacetylase-1 (HDAC) and can thus mediate the condensation of chromatin (Chen et al., 1999) . In a transient reporter assay, the transcription driven by ␤-catenin/TCF could completely be repressed by coexpression of Grg expression constructs Cavallo et al., 1998) . In mammals, all members of the TCF family can bind to all Grgs; the combinations appear to be equally potent in repressing transcription (Brantjes et al., 2001) . The shorter Grg family member, Grg-5, fails to bind to HDAC, acting thereby as a derepressor Brantjes et al., 2001) .
In Drososphila, another repressor of ␤-catenin/TCF was identified as CBP (Waltzer and Bienz, 1998) . This was rather surprising, as CBP is a strong coactivator for dozens of other transcription factors, including ␤-catenin. CBP binds to the HMG box and subsequently acetylates a specific lysine in the N-terminal ␤-catenin interaction domain. This leads to decreased binding of ␤-catenin to TCF, resulting in lower transactivation. The lysine to be acetylated, K25, is absent from the N termini of TCF-1, TCF-3, and the worm POP-1. This suggests that this mode of modulating ␤-catenin/Tcfmediated signaling may be dependent on the identity of the TCF/Lef family member. The phenotype of the dCBP mutant embryos suggests that this activity of dCBP primarily antagonizes Wnt signaling in cells which are only stimulated weakly (Waltzer and Bienz, 1998) . Finally, another protein found to function as corepressor for a subset of the TCF family was described by Moon and coworkers (Brannon et al., 1999) . C-terminal binding protein (CtBP) binds to a sequence only present in the C terminus of XTcf-3 and TCF-4, thereby converting these TCF proteins into repressors.
Taken together, TCFs act as repressors in the absence of Wnt signaling (see below) by complex formation with one of several corepressors. Transcriptional repression involves histone deacetylation, but may utilize other yet unidentified mechanisms. Upon the delivery of a Wnt signal, complex formation with ␤-catenin recruits histone acetylases (CBP) and chromatin remodelers (Brg1) to TCF target genes to transiently activate their transcription.
TCF AND WNT-SIGNALING
The identification of ␤-catenin as a binding partner of TCF answered two questions at once. It provided a mechanism by which TCF could regulate transcription, and also revealed the nature of the final step in the Wnt cascade. ␤-Catenin was the most downstream protein in the Wntsignaling cascade known at the time, but it was unclear how ␤-catenin was able to transduce the signal into the nucleus, as ␤-catenin has no DNA-binding properties. TCF, on the other hand, was known to bind to DNA, but by itself did not regulate transcription. Now that ␤-catenin and TCF were found to interact, TCF could be placed downstream of ␤-catenin in the Wnt-signaling cascade.
THE CORE OF THE WNT PATHWAY
The Wnt/wingless proteins constitute a large family of cysteine-rich glycoproteins. Wnts function as ligands for members of the Frizzled (Fz) family of serpentine receptors (Bhanot et al., 1996) . Low-density lipoprotein (LDL) receptor-related proteins (LRPs) act in synergy with Fz. The extracellular domains of both proteins interact, and signaling of Wnt is only mediated when both Fz and LRP are complexed with Wnt-1 (Tamai et al., 2000; Wehrli et al., 2000; Pinson et al., 2000) .
In unstimulated cells, ␤-catenin resides in a large cytoplasmic complex consisting of the tumor suppressor APC (adenomatous polyposis coli), GSK-3␤ (glycogen synthase kinase 3␤), and Axin (Behrens et al., 1998; Kishida et al., 1998; Ikeda et al., 1998) . In this destruction complex, ␤-catenin is phosphorylated by the serine/threonine kinase GSK-3␤ on four N-terminal serine and threonine residues. The phosphorylated residues are recognized by ␤-TrCP, which resides in an E3 ubiquitin ligase complex. Ubiquitination of ␤-catenin induces its rapid proteasomal degradation (Orford et al., 1997) . Upon Wnt binding to its receptors, the Wnt-signaling cascade is activated (Fig. 2) . This results in inhibition of the constitutive activity of GSK-3␤ (Siegfried et al., 1994; Dominguez et al., 1995; He et al., 1995; Cook et al., 1996) . Consequently, ␤-catenin is no longer phosphorylated and can accumulate in the cytoplasm and nucleus (Funayama et al., 1995; Schneider et al., 1996; Yost et al., 1996) . Nuclear ␤-catenin interacts with members of the TCF family, resulting in target gene transcription (Molenaar et al., 1996; Brunner et al., 1997; Riese et al., 1997; van de Wetering et al., 1997) . (For a more detailed description of the Wnt signaling cascade see reviews in Wodarz and Nusse, 1998; Miller et al., 1999; Polakis, 2000; Peifer and Polakis, 2000.) The involvement of TCF/LEF in the Wnt-signaling pathway was first addressed in Xenopus laevis. The role of ␤-catenin in dorsal axis formation had been known for years (Heasman et al., 1994) . Ventral microinjection of ␤-catenin mRNA in embryos induces axis duplication. This phenotype could be prevented by coinjecting mRNA encoding an XTcf-3 protein lacking the ␤-catenin binding domain. Dorsal injection of this Tcf mutant could also block endogenous head induction (Molenaar et al., 1996) . Injections of Lef-1 mRNA lacking the HMG box also inhibited head induction (Behrens et al., 1996; Huber et al., 1996) . These data proved that the direct interaction of ␤-catenin with TCF/LEF is essential for normal axis specification in Xenopus and tentatively placed TCF/LEF directly downstream of ␤-catenin in the Wnt cascade.
Since the experiments in Xenopus largely relied on overexpression of proteins, definitive proof of the role of Tcf in the Wnt signaling cascade was subsequently sought from genetic experiments in Drosophila. Two labs independently cloned the fly homologue of Tcf, dTcf or pangolin (van de Wetering et al., 1997; Brunner et al., 1997) . dTcf binds a Tcf DNA motif and, together with the fly ␤-catenin homologue armadillo, transactivates transcription of reporter genes.
FIG. 2.
Model of the Wnt signaling cascade. This simplified scheme depicts the differences between a nonsignaling cell and its signaling counterpart.
van Noort and Clevers
The isolation of dTcf-mutant flies revealed segment polarity phenotypes as expected for Wnt pathway mutants. Loss-of-function mutations in dTcf were dominant over gain-of-function mutations in armadillo (van de Wetering et al., 1997) , confirming the observations in X. laevis (see above). Moreover, murine Lef-1 overexpression in transgenic flies was found to mimic hyperstimulation of the Wnt pathway (Bruhn et al., 1997) .
Studies in the nematode C. elegans on the role of ␤-catenin and TCF were complicated for two reasons. First, at least two different Wnt signal transduction cascades exist. Second, the C. elegans genome harbors three ␤-catenin homologues: WRM-1, BAR-1, and HMP-2. Wnt signaling was originally studied in the specification of the endoderm (E) and mesoderm (MS) cells from a common precursor (EMS) at the four-to eight-stage. In this pathway, the ␤-catenin homologue WRM-1 unexpectedly opposes the activity of the Tcf homologue POP-1. This activity requires the formation of a ternary complex with the MAP kinaselike LIT-1 protein (Lin et al., 1995; Rocheleau et al., 1999) . Reinterpretation of these data suggests that, in the EMS Wnt pathway, the Tcf homologue POP-1 only acts as a repressor. Activation of LIT-1/WRM1 by Wnt signaling results in the inactivation of the repressive POP-1. This alternative Wnt pathway may also exist in mammals (Ishitani et al., 1999) .
More recently published data demonstrate that a canonical Wnt signaling pathway does exist in C. elegans. The pathway utilizes one of the other ␤-catenin homologs, BAR-1, in conjunction with the Tcf homologue POP-1. BAR-1 acts like ␤-catenin in activating target genes in response to Wnt signals. Developmental events controlled by BAR-1/POP-1 in this canonical Wnt pathway include vulva development and migration of a specific neuron, the Q cell, and its offspring (Korswagen et al., 2000) .
MUTATIONAL ACTIVATION OF TCF IN CANCER
Wnt-1 was first identified by retroviral integration in mammary tumors in mice, implying that Wnt-signaling plays a role in tumor development. Wnts do not appear to play a dominant role in human cancer. Rather, mutations in downstream components of the Wnt cascade are a major cause of several types of cancer. APC is mutated at both alleles in 80% of all colon carcinomas (Polakis et al., 1999) . These mutations almost invariably lead to a truncation of APC, removing its interaction domains for ␤-catenin and axin. As a consequence, the activity of the destruction complex is impaired and cytosolic ␤-catenin is no longer phosphorylated and degraded, but rather accumulates. The accumulated ␤-catenin in turn inappropriately activates one of the TCF/LEF family members that is specifically expressed in the intestinal epithelium, TCF-4 . In a significant fraction of sporadic colon tumors lacking APC mutations, mutations were found in the CTNNB1 (␤-catenin) gene. These mutations occur in or around the third exon, which encodes the putative phosphorylation sites of GSK-3␤ and remove the target residues of this kinase Polakis et al., 1999) . Mutations in ␤-catenin are not only found in intestinal tumors. The CTNNB1 gene has been sequenced extensively in various other tumors. An overview of the mutations found in ␤-catenin can be found at the Wnt-signaling website (www.ana.ed.ac.uk/rnusse/pathways/bcatmut.html). As the exception that proves the rule, rare mutations in Axin/Conduction have also been found in colon tumors and other types of malignancies (Webster et al., 2000) .
Taken together, mutations in APC, axin, and ␤-catenin share a common denominator, in that they all lead to the formation of ␤-catenin/TCF complexes. This implies that the inappropriate activation of TCF target genes in epithelial cells represents the primary event in cellular transformation (reviewed in Polakis, 2000; ).
THE BIOLOGY OF INTESTINAL CRYPT CELLS
Why would the inappropriate activation of TCF provide such a potent transforming signal? These data imply an important role for TCF-4 in the physiology of the intestinal epithelium. This epithelium consists of alternating crypts and villi (Potten and Loeffler, 1990) . The proliferating stem cell population is located in the crypts, from which cells slowly migrate up toward the villus. These cells differentiate into various distinct cell types. Once reaching the apex of the villus, the cells die and are shed into the gut lumen. A Wnt signal activates Tcf-4 to instruct epithelial cells to adopt a stem cell phenotype. It is obvious how the inappropriate activation of Tcf-4 would result in the unrestrained proliferation of undifferentiated cells. Abnormal outpocketing of the intestinal epithelium at the crypt-villus border is the first sign of polyp formation. This pocket protrudes into the inside of the neighboring villus, subsequently filling the total space. APC loss and the subsequent stabilization of ␤-catenin results in an increase in size of the proliferative compartment in the crypt region. As Tcf4 expression is required for crypt maintenance, it is likely that inappropriate Tcf4/␤-catenin signaling is responsible for this phenomenon. Cells that normally would start to differentiate when migrating up the crypt-villus axis now are kept in a proliferative and nondifferentiated state; in other words, they remain crypt cells. This is supported by the fact that ␤-catenin has been observed to suppress differentiation (Harada et al., 1999) .
A number of TCF target genes have been proposed to play a role in the transformation of intestinal epithelial cells. These include c-MYC (He et al., 1998) , cyclin D1 (Tetsu and McCormick, 1999) , TCF-1 (Roose et al., 1999) , gastrin (Koh et al., 2000) , and PPAR␦ (He et al., 1999) . For a complete list visit the Wnt website: www.ana.ed.ac.uk/rnusse/wntwindow. html. Although these target genes may play a role in cellular transformation, these studies provide only snapshots of the entire TCF target gene program in colorectal cancer. Global insights into this genetic program will undoubtedly be generated in the near future through the application of DNA array analysis.
The detailed molecular understanding of the Wntsignaling cascade now allows the search for drugs that selectively target specific steps of the pathway. Structures of the ␤-catenin/Tcf3 and ␤-catenin/E-cadherin complexes have recently been elucidated (Graham et al., 2000; Huber and Weis, 2001 ). Birchmeier and colleagues have performed an extensive mutational analysis of the basic groove that runs along the length of the armadillo-repeat region of ␤-catenin (von Kries et al., 2000) . This groove binds Tcf, E-cadherin, and APC in a mutually exclusive fashion. In addition, it binds axin. This study revealed unique hotspots in the groove for each of these four interaction partners. This has raised hopes that unique inhibitors can be designed for the ␤-catenin/Tcf interaction. Such inhibitors may constitute highly precise drugs for the treatment of colorectal cancer.
